Patent Application
20050228175
1. Field of the Invention
The present invention relates to methods for producing 2-deoxy-L-ribose compounds, namely, 2-deoxy-L-ribose itself and protected forms thereof. The present invention also relates to reactive derivatives thereof and the like, and a novel intermediate compound useful for the production of such reactive derivatives.
2. Discussion of the Background
2-Deoxy-L-ribose (L-deoxyribose) is known to be a compound useful as a starting material for the production of an L type nucleic acid derivative that is drawing attention in recent years as a pharmaceutical product such as an antiviral agent and the like (see, WO 01/034618 and WO 02/044194). In addition, 2-deoxy-L-ribose itself has been reported to have an angiogenesis inhibitory activity (see, WO 02/051423).
As production methods of 2-deoxy-L-ribose, synthetic methods using an L-sugar or a D-sugar as a starting material have been generally tried. However, these methods require a great many steps. Particularly, while the use of an L-sugar as a starting material is advantageous for the production of 2-deoxy-L-ribose, which is the same L-sugar, L-sugar scarcely occurs in nature and is difficult to obtain, and the only known industrially available L-sugar is L-arabinose. L-Arabinose is a structurally similar L-sugar, which becomes 2-deoxy-L-ribose when the 2-position hydroxyl group is deoxylated. However, even when 2-deoxy-L-ribose is produced using L-arabinoseas a starting material, the number of steps is six, and the total yield is not more than 30% (see, Tetrahedron Asymmetry, vol. 13, pp. 2667-2672 (2002)).
On the other hand, as a production method that does not use sugar as a starting material, a method using L-glyceraldehyde as a starting material has been reported (see, Chinese Journal of Chemistry, vol.20, pp. 1358-1362 (2002)). According to this method, L-glyceraldehyde is propargylated, the hydroxyl group is protected, hydrogenation using a Lindlar catalyst and ozone oxidization are performed to give an aldehyde compound, and finally, the protected hydroxyl group is deprotected to synthesize 2-deoxy-L-ribose. However, according to this method, again, production of 2-deoxy-L-ribose from L-glyceraldehyde requires five steps, and this method is not necessarily an efficient production method. In addition, ozone oxidization is not a step suitable for industrial practice, and a production method of 2-deoxy-L-ribose, which is more efficient and suitable for industrial production, has been desired.
Thus, there remains a need for an improved method for making 2-deoxy-L-ribose.
Accordingly, it is one object of the present invention to provide novel methods for the production of 2-deoxy-L-ribose.
It is another object of the present invention to provide novel efficient methods for the production of 2-deoxy-L-ribose.
It is another object of the present invention to provide novel methods which are suitable for the industrial production of 2-deoxy-L-ribose.
It is another object of the present invention to provide novel methods for the production of protected forms of 2-deoxy-L-ribose.
It is another object of the present invention to provide novel efficient methods for the production of protected forms of 2-deoxy-L-ribose.
It is another object of the present invention to provide novel methods which are suitable for the industrial production of protected forms of 2-deoxy-L-ribose.
It is another object of the present invention to provide a novel intermediate compound useful in such methods.
It is another object of the present invention to provide novel methods for preparing an L-nucleic acid derivative by using the 2-deoxy-L-ribose or derivative thereof produced by the present method.
It is another object of the present invention to provide novel methods for preparing a 2′-deoxy-L-nucleoside by using the 2-deoxy-L-ribose or derivative thereof produced by the present method.
Thus, the present invention aims at the provision of an efficient production method suitable for industrial production of 2-deoxy-L-ribose, a protected form thereof and the like, and a novel intermediate compound useful for the production of these.
These and other objects, which will become apparent during the following detailed description, have been achieved by the inventors' discovery that 2-deoxy-L-ribose can be obtained by reacting an aldehyde compound represented by the formula (1) described below with an organometallic compound represented by the formula (2) described below to give an alcohol compound represented by the formula (3) described below, and subjecting this compound to deprotection of hydroxyl group and aldehyde production by acid hydrolysis. Furthermore, a hydroxyl group of 2-deoxy-L-ribose can be protected easily to afford a more stable protected form. Moreover, the present inventors have found a method of conveniently purifying a hydroxyl-protected form of the obtained 2-deoxy-L-ribose, which resulted in the completion of the present invention.
Thus, the present invention provides the following:
(1) A method for producing a 2-deoxy-L-ribose compound, which comprises:
(2) The method of the above-mentioned (1), which affords 2-deoxy-L-ribose.
(3) The method of the above-mentioned (1), which further comprises:
(4) The method of the above-mentioned (3), wherein, in (c), a protecting group is introduced into the 1-position hydroxyl group of 2-deoxy-L-ribose to give a 1-position hydroxyl-protected form of 2-deoxy-L-ribose.
(5) The method of the above-mentioned (4), wherein, in (c), the protecting group of the 1-position hydroxyl group is introduced by the acid hydrolysis in (b), which is performed in the co-presence of an acid and an alcohol.
(6) The method of the above-mentioned (5), wherein the alcohol is methanol.
(7) The method of any of the above-mentioned (4) to (6), wherein the 1-position hydroxyl-protected form of 2-deoxy-L-ribose is of a furanose type.
(8) A method for producing a furanose type 2-deoxy-L-ribose compound represented by formula (8):
wherein X1 is a leaving group, R8 and R9 are each independently a hydroxyl-protecting group or R8 and R9 in combination form a hydroxyl-protecting group, which method comprises protecting the 3-position and the 5-position hydroxyl groups of the furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose obtained by the production method of the above-mentioned (7), and then converting the protected 1-position hydroxyl group to a leaving group.
(9) The method of the above-mentioned (8), wherein X1 is a chlorine atom and R8 and R9 are each a p-toluoyl group.
(10) The method of any of the above-mentioned (1) to (9), wherein R1 and R2 are each independently a hydroxyl-protecting group, which can be deprotected by acid hydrolysis, or R1 and R2 in combination form a hydroxyl-protecting group, which can be deprotected by acid hydrolysis, and the deprotection of the hydroxyl group and the production of aldehyde by acid hydrolysis of (b) are simultaneously performed.
(11) The method of the above-mentioned (10), wherein R1 and R2 in combination form a cyclic acetal type hydroxyl-protecting group, which can be deprotected by acid hydrolysis.
(12) The production method of any of the above-mentioned (1) to (11), wherein M is Li, MgX2 or ZnX2 (X2 is a halogen atom).
(13) The method of the above-mentioned (11), wherein the aldehyde compound represented by the formula (1) is an aldehyde compound represented by formula (1-a):
the organometallic compound represented by the formula (2) is an organometallic compound represented by formula (2-a):
wherein M1 is Li, MgX2 or ZnX2 (X2 is a halogen atom), and the alcohol compound represented by the formula (3) is an alcohol compound represented by formula (3-a):
(14) A method for producing a furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose, which method comprises reacting a mixture of a furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose and a furanose type 1-position hydroxyl-protected form of 2-deoxy-L-xylose with a ketone compound represented by formula (5):
wherein R5 and R6 are each independently an alkyl group, an aralkyl group, or an aryl group, or R5 and R6 in combination form an alkylene group, in the presence of an acid, to preferentially protect the 3-position and the 5-position hydroxyl groups of the furanose type 1-position hydroxyl-protected form of 2-deoxy-L-xylose and give a furanose type 2-deoxy-L-xylose compound represented by formula (6):
wherein R5 and R6 are as defined above and R7 is an alkyl group or an aralkyl group, and then separating an unreacted furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose from the furanose type 2-deoxy-L-xylose compound represented by the aforementioned formula (6).
(15) The method of the above-mentioned (14), wherein the ketone compound represented by formula (5) is acetone.
(16) The method of the above-mentioned (14) or (15), wherein the separation comprises separation of water from an organic solvent.
(17) A method for producing a furanose type 2-deoxy-L-ribose represented by formula (8):
wherein X1 is a leaving group, R8 and R9 are each independently a hydroxy-protecting group or R8 and R9 in combination form a hydroxyl-protecting group, which method comprises protecting the 3-position and the 5-position hydroxyl groups of the furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose obtained by the production method of any of the above-mentioned (14) to (16), and then converting the protected 1-position hydroxyl group to a leaving group.
(18) The method of the above-mentioned (17), wherein X1 is a chlorine atom and R8 and R9 are p-toluoyl groups.
(19) The method of any of the above-mentioned (14) to (18), wherein the mixture containing a furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose and a furanose type 1-position hydroxyl-protected form of 2-deoxy-L-xylose are obtained by the production method of any of the above-mentioned (4) to (6).
(20) The method of the above-mentioned (19), wherein R1 and R2 are each independently a hydroxyl-protecting group, which can be deprotected by acid hydrolysis, or R1 and R2 in combination form a hydroxyl-protecting group, which can be deprotected by acid hydrolysis, and the deprotection of the hydroxyl group and the production of aldehyde by acid hydrolysis of (b) are simultaneously performed.
(21) The method of the above-mentioned (20), wherein R1 and R2 in combination form a cyclic acetal type hydroxyl-protecting group, which can be deprotected by acid hydrolysis.
(22) The method of any of the above-mentioned (19) to (21), wherein M is Li, MgX2 or ZnX2 (X2 is a halogen atom).
(23) The method of the above-mentioned (21), wherein the aldehyde compound represented by the formula (1) is an aldehyde compound represented by formula (1-a):
the organometallic compound represented by formula (2) is an organometallic compound represented by formula (2-a):
wherein M1 is Li, MgX2 or ZnX2 (X2 is a halogen atom), and the alcohol compound represented by the formula (3) is an alcohol compound represented by formula (3-a):
(24) A compound represented by formula (3):
wherein R1 and R2 are each independently a hydroxyl-protecting group or R1 and R2 in combination form a hydroxyl-protecting group, R3 and R4 are each independently an alkyl group, an aralkyl group, an aryl group or a silyl group or R3 and R4 in combination form an alkylene group.
(25) A compound represented by formula (3-a):
According to the present invention, 2-deoxy-L-ribose and a protected form thereof can be efficiently produced by a small number of steps, and this method is an industrially suitable method.
The 2-deoxy-L-ribose compound of the present invention encompasses the 2-deoxy-L-ribose itself and a hydroxyl-protected form thereof.
The method of producing the 2-deoxy-L-ribose compound of the present invention essentially comprises steps (a) and (b).
In step (a), an aldehyde compound represented by formula (1):
wherein R1 and R2 are each independently a hydroxyl-protecting group or R1 and R2 in combination form a hydroxyl-protecting group is reacted with an organometallic compound represented by formula (2):
wherein R3 and R4 are each independently an alkyl group, an aralkyl group, an aryl group or a silyl group or R3 and R4 in combination form an alkylene group, M is a metal atom or a metal salt to give an alcohol compound represented by formula (3):
wherein R1, R2, R3 and R4 are as defined above.
The aldehyde compound represented by formula (1) can be produced easily by converting an amino group of L-serine to a hydroxyl group, esterifying a carboxyl group, protecting the hydroxyl group to synthesize methyl 2,3-O-protected-L-glycerate (see, Helvetica Chimica Acta, vol. 68, pp. 1863-1871 (1985) etc.), and reducing this compound to give a 2,3-O-protected-L-glyceraldehyde compound.
The organometallic compound represented by formula (2) can be synthesized easily by halogenation of vinyl acetate as a starting material in a methanol solution to give a dimethyl acetal of halogenated acetaldehyde, which is followed by conversion of the protecting group to give a protected form of halogenated acetaldehyde (see, GB patent publication No.2146016), which is then reacted with metal to give the object compound. It can be also prepared by synthesizing a protected acetaldehyde using acetaldehyde as a starting material and halogenating the same (see, WO99/217346 and EP-A-413558, etc.).
The hydroxyl-protecting group for R1 or R2 is not particularly limited as long as it is a hydroxyl-protecting group and, for example, cyclic acetal type protecting groups such as methoxymethylene acetal group, isopropylidene group, methylene acetal group, and ethylidene acetal group; methyl group; benzyl group; benzoyl group; t-butyl group; acetyl group; methoxymethyl group; 2-methoxyethoxymethyl group; trimethylsilyl group; triethylsilyl group; t-butyldimethylsilyl group; methylthiomethyl group; trifluoroacetyl group; benzyloxycarbonyl group; t-butoxycarbonyl group; triphenylmethyl group; toluoyl group; 4-methoxymethylphenyl group; and the like can be mentioned.
As the hydroxyl-protecting group for R1 or R2, a hydroxyl-protecting group, which can be deprotected by acid hydrolysis, is preferable. As the hydroxyl-protecting group, which can be deprotected by acid hydrolysis, for example, cyclic acetal type protecting groups such as methoxymethylene acetal group, isopropylidene group, methylene acetal group, and ethylidene-acetal group; methoxymethyl group; trimethylsilyl group; triethylsilyl group; t-butyldimethylsilyl group; methylthiomethyl group; benzyloxycarbonyl group; t-butoxycarbonyl group; triphenylmethyl group; and the like can be mentioned.
As R1 or R2, from the aspect of the stereoselectivity of the reaction, cyclic acetal type protecting groups such as methoxymethylene acetal group, isopropylidene group, methylene acetal group, and ethylidene acetal group are preferable, which are formed by R1 and R2 in combination, and an isopropylidene group is particularly preferable.
As the “alkyl group” for R3 or R4, a linear or branched chain alkyl group having preferably 1-20, more preferably 1-7, carbon atoms can be mentioned. Specifically, for example, alkyl group such as methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, lauryl group, and the like can be mentioned.
The alkyl group is optionally substituted by one or more substituents below. As the substituent used herein, for example, a linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g.: methoxy group and the like), a halogen atom (e.g., chlorine atom, fluorine atom and the like), a hydroxyl group and the like can be mentioned. It is needless to say that the “alkyl group having a substituent” is encompassed by the term “alkyl group” in the present invention.
The “aralkyl group” for R3 or R4 is one wherein the aryl moiety preferably has 6-12, more preferably 6-8, carbon atoms, and the alkyl moiety is a linear or branched chain alkyl group preferably having 1-6, more preferably 1-3, carbon atoms. Specific examples of the aralkyl group preferably include a benzyl group;
The aralkyl group is optionally substituted by one or more substituents below. As the substituent here, for example, a nitro group, a linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g.: methoxy group and the like), a halogen atom (e.g., chlorine atom, fluorine atom, and the like), a hydroxyl group and the like can be mentioned. It is needless to say that the “aralkyl group having a substituent” is encompassed by the term “aralkyl group” in the present invention.
As the “aryl group” for R3 or R4, an aryl group preferably having 6-20, more preferably 6-8, carbon atoms can be mentioned. The aryl group is optionally substituted by one or more substituents below. As the substituent here, for example, a nitro group, a linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g.: methoxy group and the like), a halogen atom (e.g., chlorine atom, fluorine atom, and the like), a linear or branched chain alkyl group (preferable carbon number: 1-4, e.g.: methyl group, ethyl group, propyl group and the like), a hydroxyl group and the like can be mentioned. It is needless to say that the “aryl group having substituent” is encompassed by the term “aryl group” in the present invention. Specific examples of the aryl group optionally having substituents include a phenyl group, o-, m-, or p-nitrophenyl group, o-, m-, or p-methoxyphenyl group, o-, m-, or p-chlorophenyl group, o-, m-, or p-fluorophenyl group, o-, m-, or p-tolyl group, and the like.
As the “silyl group” for R3 or R4, for example, a trimethylsilyl group, a triethylsilyl group, triisopropylsilyl, and a t-butyldimethylsilyl group can be mentioned. Particularly, a t-butyldimethylsilyl group is preferable.
When R3 and R4 in combination form an alkylene group, an alkylene group having 2-6 carbon atoms is preferable. The resulting cyclic alkyl group which contains R3 and R4 is optionally substituted by one or more substituents below. As the substituent here, for example, a nitro group, a linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g., methoxy group and the like), a halogen atom (e.g., chlorine atom, fluorine atom, and the like), a linear or branched chain alkyl group (preferable carbon number: 1-4, e.g., methyl group, ethyl group, propyl group, and the like), a hydroxyl group, and the like can be mentioned. It is needless to say that the “cyclic alkyl group having substituent” is encompassed by the term “cyclic alkyl group” in the present invention.
As the metal atom for M, lithium atom (Li), sodium atom (Na), potassium atom (K), and the like can be mentioned. As the metal salt for M, magnesium halide (MgX2), zinc halide (ZnX2), and the like can be mentioned. As M, lithium atom, magnesium halide (MgX2) and zinc halide (ZnX2) are particularly preferable. Here, X2 means a halogen atom, and as the halogen atom, bromine atom, chlorine atom, and iodine atom are preferable, and bromine atom is particularly preferable.
As the aldehyde compound represented by formula (1), an aldehyde compound represented by formula (1-a):
wherein a hydroxyl group is protected by an isopropylidene group, is preferable in view of the stereoselectivity of the reaction and comparatively easy production and availability.
As the organometallic compound represented by formula (2), an organometallic compound represented by the following formula (2-a)
wherein M1 is Li, MgX2 or ZnX2, wherein X2 is a halogen atom and R3 and R4 in combination form an alkylene group having 2 carbon atoms, is particularly preferable, in view of comparatively easy production and availability.
As the halogen atom represented by X2, a chlorine atom, a bromine atom, and an iodine atom are preferable, and bromine atom is particularly preferable.
Of the organometallic compounds represented by formula (2-a), an organometallic compound represented by the following formula (2-b) is preferable.
The organometallic compound represented by the formula (2) is used in a ratio of generally 0.5 molar equivalent to 2 molar equivalents, preferably 1 molar equivalent to 1.5 molar equivalents, relative to the aldehyde compound represented by formula (1). The reaction is generally carried out in a suitable organic solvent. The organic solvent to be used is not particularly limited as long as it is inert to the reaction and, for example, ethers such as diethyl ether, diisopropyl ether, dimethyl ether, t-butyl methyl ether, dibutyl ether, petroleum ether, and the like, cyclic ethers such as tetrahydrofuran (THF), dioxane, and the like, benzene, toluene, xylene, butane, pentane, hexane, heptane, and the like can be mentioned. Particularly, tetrahydrofuran and diethyl ether are preferable. These organic solvents are preferably used after dehydration and purging with an inert gas. The amount of the solvent to be used is not particularly limited but is generally in a weight ratio of 0.5- to 200-fold, preferably 1- to 10-fold, relative to the aldehyde compound.
The reaction temperature is generally !78° C. to 100° C., preferably !30° C. to 66° C. The reaction time is not particularly limited but generally 10 minutes to 24 hours, preferably 30 minutes to 5 hours, in the above-mentioned temperature range.
In step (a), the organometallic compound represented by formula (2) may be prepared in a reaction vessel by a reaction with a suitable reagent. For example, 2-bromomethyl-1,3-dioxolane is reacted with magnesium in a reaction vessel to give (1,3-dioxolan-2-ylmethyl)-magnesium bromide. Similarly, 2-bromomethyl-1,3-dioxolane is reacted with zinc to give (1,3-dioxolan-2-ylmethyl)-zinc bromide. In addition, 2-bromomethyl-1,3-dioxolane is reacted with lithium diisopropylamide to give (1,3-dioxolan-2-ylmethyl)-lithium.
After the completion of the reaction, an alcohol compound represented by formula (3) may be isolated from the reaction solution by a method known to those of ordinary skill in the art, such as chromatography and the like. It is also possible to use the reaction solution as it is for the next step without isolation, and, where necessary, a different solvent may be added after concentration or evaporation of the reaction solution and used for the next step.
As for the alcohol compound represented by formula (3), which is obtained in step (a), it is possible to highly stereoselectively obtain one having the R steric configuration at the 3-position. In this case, the 3-position S form, which is generated as a minor component, can be removed by chromatography. However, in view of the fact that the 3-position R form and the 3-position S form are diastereomers having similar properties and industrial purification thereof by chromatography is practically difficult, without performing purification at this stage, it is preferable to remove a by-product derived from the 3-position S form in step (d) to be mentioned later.
An embodiment of the synthesis of an alcohol compound, which comprises reacting 2,3-O-isopropylidene-D-glyceraldehyde, which is an optical isomer of an aldehyde compound represented by formula (1-a) in the present invention, with (1,3-dioxolan-2-ylmethyl)-magnesium bromide is described in WO 03/000200 (FIG. 1 and Example 1 on page 66). However, production of a compound having the same steric configuration as the alcohol compound represented by formula (3) has not been known. In addition, WO 03/000200 does not describe the stereoselectivity of the above-mentioned reaction and it was first found in the present invention that a compound represented by formula (3), which has the R steric configuration at the 3-position, can be obtained stereoselectively. In this reference, moreover, the obtained alcohol compound is oxidized to convert to a carbonyl group and therefore, it is clear that this invention does not aim at production of 2-deoxyribose utilizing stereoselectivity of alcohol compound as in the present invention.
Step (b) comprises subjecting an alcohol compound represented by formula (3) to elimination of a hydroxyl-protecting group and production of aldehyde by acid hydrolysis. An alcohol compound represented by formula (3) can be converted to 2-deoxy-L-ribose by eliminating a hydroxyl-protecting group represented by R1 or R2 to give a hydroxyl group, and hydrolyzing a group represented by R3 or R4 with an acid to give an aldehyde group.
When the hydroxyl-protecting group represented by R1 or R2 is a hydroxyl-protecting group, which can be deprotected by acid hydrolysis, deprotection of the hydroxyl group and generation of aldehyde can be simultaneously performed by acid hydrolysis and 2-deoxy-L-ribose can be produced in a single step. When a hydroxyl-protecting group represented by R1 or R2 cannot be removed by acid hydrolysis, deprotection of the hydroxyl group is performed independently of the aldehyde producing reaction. In this case, the deprotection is preferably performed before the aldehyde producing reaction. Deprotection of the hydroxyl group is performed by a method known to those of ordinary skill in the art.
As the acid to be used in step (b), acetic acid, trifluoroacetic acid, hydrochloric acid, sulfuric acid, strong acidic resin, and the like can be mentioned, and acetic acid and hydrochloric acid are particularly preferable. The amount of the acid to be used is not particularly limited, but it is generally preferably 0.1 molar equivalent to 200 molar equivalents, preferably 1 molar equivalent to 50 molar equivalents, relative to the alcohol compound represented by formula (3).
The acid hydrolysis can be performed by, for example, dropwise addition of an acid to a solvent in which the alcohol compound represented by formula (3) has been dissolved. In this case, it is preferable to dissolve the alcohol compound represented by formula (3) in an organic solvent immiscible with water and dropwise add an aqueous acid solution, so as to suppress any side reaction by the acid. As preferable organic solvents, methylene chloride, chloroform, tetrahydrofuran, and the like can be mentioned. Methylene chloride is particularly preferable. The amount of the organic solvent to be used is not particularly limited but is generally in a weight ratio of 1- to 200-fold, preferably 10- to 50-fold, relative to the alcohol compound represented by formula (3). While the concentration of the aqueous acid solution is not particularly limited, either, the acid is generally used in a volume ratio of 0.1-100%, preferably 5-80%, of the water.
The reaction temperature of the acid hydrolysis is generally 0° C. to 100° C., preferably 10° C. to 50° C. The reaction time is not particularly limited but the reaction completes in the above-mentioned temperature range generally for 10 minutes to 6 hours, preferably 30 minutes to 2 hours.
After the completion of the reaction, the 2-deoxy-L-ribose in the reaction solution may be isolated by any method known to those of ordinary skill in the art, such as chromatography and the like. In addition, the reaction solution may be used as it is in the next step without isolation, and where necessary, the reaction solution may be concentrated or evaporated, added with a different solvent and used in the next step.
In step (c), at least one hydroxyl group of 2-deoxy-L-ribose obtained in step (b) is protected to give a hydroxyl-protected form of 2-deoxy-L-ribose. This step is optionally employed when producing a protected form of 2-deoxy-L-ribose.
In step (c), a hydroxyl group of 2-deoxy-L-ribose can be protected by any method known to those of ordinary skill in the art. As the protecting group, those known as a hydroxyl-protecting group can be used, such as methyl group, benzyl group, 4-methoxymethylphenyl group, methoxymethyl group, trimethylsilyl group, triethylsilyl group, t-butyldimethylsilyl group, acetyl group, benzoyl group, toluoyl group, isopropylidene group, methylthiomethyl group, 2-methoxyethoxymethyl group, trifluoroacetyl group, t-butyl group, benzyloxycarbonyl group, t-butoxycarbonyl group, triphenylmethyl group, and the like.
In the acid hydrolysis of step (b), the 1-position hydroxyl group is selectively protected in the co-presence of an acid and an alcohol, whereby step (c) can be performed simultaneously. In other words, a 1-position hydroxyl-protected form of 2-deoxy-L-ribose, wherein the 1-position hydroxyl group is protected by an alkyl group corresponding to the alcohol used, can be produced in a single step. The 1-position hydroxyl-protected form can fix the skeleton of 2-deoxy-L-ribose in an equilibrium state. Therefore, it is advantageous for isolation and purification and derivatization thereafter. As preferable alcohols, alcohols having 1-8 carbon atoms can be mentioned. To be specific, alcohols such as methanol, ethanol, isopropyl alcohol, butyl alcohol, benzyl alcohol, and the like can be mentioned, with particular preference given to methanol. The amount of the alcohol to be used is not particularly limited, but is generally in a weight ratio of 1- to 200-fold, preferably 5- to 50-fold, relative to the alcohol compound represented by formula (3).
When R7OH is the alcohol used, the thus-obtained 1-position hydroxyl-protected form of 2-deoxy-L-ribose is generally obtained as a mixture of a furanose type represented by the following formula (4) and a pyranose type represented by the formula (4′). As a starting material of a pharmaceutical product, a furanose type is preferable, wherein R7 is an alkyl group or an aralkyl group. An alkyl group and an aralkyl group having 1-8 carbon atoms are preferable. As the specific alcohol, those mentioned above can be mentioned.
After the completion of the reaction of step (c), a hydroxyl-protected form of 2-deoxy-L-ribose may be isolated from the reaction solution by any method known to those of ordinary skill in the art such as chromatography and the like. When the object product of step (c) is the above-mentioned furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose represented by formula (4) (hereinafter to be also referred to as compound (4)), and particularly when the furanose type 1-position hydroxyl-protected form of 2-deoxy-L-xylose represented by the following formula (4-a) (hereinafter to be also referred to as compound (4-a)) derived from the 3-position S form of an alcohol compound represented by formula (3) by-produced in the above-mentioned step (a) is mixed in the reaction mixture, compound (4) can be efficiently isolated by performing the following. step (d).
As shown in the following scheme, in step (d), a mixture containing compound (4) and compound (4-a) is reacted with a ketone compound represented by formula (5) (hereinafter to be also referred to as ketone compound (5)) in the presence of an acid to preferentially protect the 3-position and the 5-position hydroxyl groups of compound (4-a) to give a furanose type 2-deoxy-L-xylose compound represented by formula (6) (hereinafter to be also referred to as compound (6)), and then unreacted compound (4) and compound (6) are separated.
wherein R5 and R6 are each independently an alkyl group, an aralkyl group or an aryl group, or R5 and R6 in combination form an alkylene group and R7 is an alkyl group or an aralkyl group.
Since compound (4) and compound (4-a) generally do not have high crystallinity, chromatography is necessary for separation. However, since compound (4) and compound (4-a) are diastereomers and have markedly similar properties, industrial practice of purification by chromatography is difficult to achieve.
When a mixture containing compound (4) and compound (4-a) is reacted with a ketone compound (5) in the presence of an acid in step (d), compound (6) is easily obtained, since the 3-position and the 5-position hydroxyl groups of compound (4-a) are in the cis-position relative to the furanose ring, and an acetal type protecting group with ketone compound (5) is formed sterically advantageously. In contrast, the 3-position and the 5-position hydroxyl groups of compound (4) are in the trans-position relative to the furanose ring, and formation of an acetal-protecting group is sterically disadvantageous. Therefore, compound (4-a) alone can be preferentially protected in step (d), and a mixture containing compound (4) and compound (6) can be obtained. Since compound (6) has considerably high lipid solubility as compared to compound (4), it can be separated easily from compound (4) by an industrially practical and convenient operation.
The 3-position and the 4-position hydroxyl groups of the pyranose type 2-deoxy-L-ribose represented by the formula (4′) are also considered to be easily protected in step (d). The protected form thereof is also advantageously separated from compound (4) along with compound (6) and other lipid soluble byproducts can be also removed by step (d).
The “alkyl group” for R5 or R6 is a linear or branched chain alkyl group preferably having 1-20, more preferably 1-7, carbon atoms. Specifically, for example, alkyl groups such as methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, lauryl group, and the like can be mentioned.
The alkyl group is optionally substituted by the one or more substituents below. As the substituent here, for example, linear or branched chain alkoxy groups (preferable carbon number: 1-6, e.g.: methoxy group and the like), halogen atoms (e.g.,: chlorine atom, fluorine atom, and the like), hydroxyl group and the like can be mentioned. It is needless to say that the “alkyl group having substituent” is encompassed by the term “alkyl group” in the context of the present invention.
The “aralkyl group” for R5 or R6 is an aralkyl group wherein the aryl moiety preferably has 6-12, more preferably 6-8, carbon atoms and the alkyl moiety is a linear or branched chain alkyl group preferably having 1-6, more preferably 1-3, carbon atoms.
The aralkyl group is optionally substituted by one or more substituents below. As the substituent here, for example, a nitro group, a linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g.: methoxy group and the like), halogen atoms (e.g.: chlorine atom, fluorine atom, and the like), hydroxyl groups, and the like can be mentioned. It is needless to say that the “aralkyl group having substituent” is encompassed by the term “aralkyl group of the present invention.” Specific examples of the aralkyl group include substituted benzyl group such as p-methoxybenzyl group, dimethoxybenzyl group and the like and a benzyl group.
As the “aryl group” for R5 or R6, an aryl group preferably having 6-20, more preferably 6-8, carbon atoms can be mentioned. The aryl group is optionally substituted by one or more substituents below. As the substituent here, for example, nitro group, linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g.: methoxy group and the like), halogen atom (e.g.: chlorine atom, fluorine atom, and the like), linear or branched chain alkyl group (preferable carbon number: 1-4, e.g.: methyl group, ethyl group, propyl group, and the like), hydroxyl group, and the like can be mentioned. It is needless to say that the “aryl group having substituent” is encompassed by the term “aryl group of the present invention.” Specific examples of the aryl group optionally having substituents include phenyl group, o-, m-, or p-nitrophenyl group, o-, m-, or p-methoxyphenyl group, o-, m-, or p-chlorophenyl group, o-, m-, or p-fluorophenyl group, o-, m-, or p-tolyl group, and the like.
When R5 and Rf6 in combination form an alkylene group, an alkylene group having 2-6 carbon atoms is preferable. The resulting cyclic alkyl group which contains R5 and R6 is optionally substituted by one or more substituents below. As the substituent here, for example, a nitro group, a linear or branched chain alkoxy group (preferable carbon number: 1-6, e.g.: methoxy group and the like), halogen atom (e.g.,: chlorine atom, fluorine atom, and the like), linear or branched chain alkyl group (preferable carbon number: 1-4, e.g.: methyl group, ethyl group, propyl group. and the like), hydroxyl group, and the like can be mentioned. It is needless to say that the “cyclic alkyl group having substituent” is encompassed by the term “cyclic alkyl of the present invention.”
As R5 and R6, an alkyl group is preferable and a methyl group is more preferable. That is, the ketone compound (5) is preferably acetone.
The “alkyl group” and “aralkyl group” for R7 are as defined above, and are preferably a methyl group.
The ketone compound (5) is used in an amount of generally 0.5 molar equivalent to 10 molar equivalents, preferably 0.8 molar equivalent to 2 molar equivalents, relative to compound (4-a). When the amount of the ketone compound (5) to be used is greater than this range, compound (4) is also likely to be protected, which is not preferable.
As the acid to be used in step (d), any acid conventionally used as an acid catalyst in an acetalized reaction can be mentioned. Specifically, mineral acids such as hydrochloric acid, sulfuric acid, phosphoric acid, and the like; organic acids such as methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, pyridinium p-toluenesulfonate, camphorsulfonic acid, trifluoroacetic acid, and the like; Lewis acid such as boron trifluoride etherate, aluminum trichloride, tin tetrachloride, titanium tetrachloride and the like; strong acidic ion exchange resins; and the like can be mentioned. Particularly, p-toluenesulfonic acid is preferable. The amount of the acid to be used is not particularly limited, but it is preferably used in an amount of generally 0.001 molar equivalent to 1 molar equivalent, preferably 0.01 molar equivalent to 0.2 molar equivalent, relative to compound (4-a). When the amount of the acid to be used is greater than this range, compound (4) unpreferably is likely to be protected.
While the reaction may be carried out in a suitable organic solvent, it is preferably carried out without solvent. When it is carried out in an organic solvent, the organic solvent to be used is not particularly limited as long as it is inert to the reaction. For example, esters such as ethyl acetate and the like, aromatic hydrocarbons such as toluene and the like, halogenated hydrocarbons such as methylene chloride, chloroform and the like are preferable. These organic solvents are preferably subjected to dehydration and purging with an inert gas before use.
The reaction temperature of step (d) is generally 5° C. to 1 00° C., preferably 10° C. to 50° C. When the reaction temperature is higher than this range, compound (4) may be also protected. The reaction time is not particularly limited and the time is appropriately determined by monitoring the reaction until almost complete disappearance of compound (4-a) by TLC and the like. For example, the reaction time is generally 30 minutes to 24 hours, preferably 1 hour to 6 hours, in the above-mentioned temperature range.
After the completion of the reaction, neutralization is performed as necessary to quench the reaction, whereby a mixture containing unreacted compound (4) and compound (6) can be obtained. From this mixture, compound (4), compound (6) and other lipid soluble contaminants can be easily separated by any industrially practical and convenient method (e.g., chromatography etc.). As an industrially preferable method, separation by partitioning between water and a suitable organic solvent can be mentioned.
In other words, since compound (4) has a considerably high water solubility, it is easily partitioned into an aqueous layer by the above-mentioned partitioning operation, compound (6) and other lipid soluble contaminants are easily partitioned into an organic layer, they can be separated easily.
The partitioning operation can be performed by sufficiently stirring a mixture containing compound (4) and compound (6) in water and an organic solvent and allowing the mixture to stand to effect phase separation.
The organic solvent to be used for the partitioning operation can be appropriately determined in consideration of the coefficient of partition of compound (4) and the like and, for example, when R7 is a methyl group, halogenated hydrocarbons such as methylene chloride, chloroform, and the like; esters such as ethyl acetate and the like; ethers such as diethyl ether and the like; and the like can be mentioned, with preference given to methylene chloride.
The ratio of the amounts of water and organic solvent in the partitioning operation can be also appropriately determined in consideration of the coefficient of partition of compound (4) and the like and, for example, when R7 is a methyl group and methylene chloride is used as an organic solvent, the volume ratio of water: methylene chloride is preferably 90:10 to 50:50.
The compound (4) partitioned into the aqueous layer by the partitioning operation can be isolated by any method known to those of ordinary skill in the art. For example, compound (4) may be re-extracted with an organic solvent permitting extraction from the aqueous layer, or a method comprising concentrating the aqueous layer and the like can be mentioned.
The furanose type 1-position hydroxyl-protected form of 2-deoxy-L-ribose (compound (4)) obtained by the present invention can be converted to a furanose type 2-deoxy-L-ribose compound represented by the formula (8), which is more preferable as an intermediate for a pharmaceutical product, by, as shown in the following reaction scheme, protecting the 3-position and the 5-position hydroxyl groups and converting the protected 1-position hydroxyl group (—OR7 in the following formula) to a leaving group:
wherein X1 is a leaving group, R8 and R9 are each independently a hydroxyl-protecting group or R8 and R9 in combination form a hydroxyl-protecting group.
The hydroxyl-protecting group for R8 or R9 is not particularly limited as long as it is a hydroxyl-protecting group and, for example, cyclic acetal type protecting groups such as methoxymethylene acetal group, isopropylidene group, methylene acetal groups and ethylidene acetal group; methyl group; benzyl group; benzoyl group; t-butyl group; acetyl group; methoxymethyl group; 2-methoxyethoxymethyl group; trimethylsilyl group; triethylsilyl group; t-butyldimethylsilyl group; methylthiomethyl group; trifluoroacetyl group; benzyloxycarbonyl group; t-butoxycarbonyl group; triphenylmethyl group; toluoyl group; 4-methoxymethylphenyl group; and the like can be mentioned.
The leaving group for X1 is not particularly limited as long as it can leave during, for example, a substitution reaction of a nucleophilic reagent (e.g., nucleic acid basic derivative such as adenine, guanine, 6-chloropurine, uracil, thymine, etc.) when a furanose type 2-deoxy-L-ribose compound represented by formula (8) is leading to a desired compound and, for example, halogen atom (e.g., chlorine atom, bromine atom, iodine atom, etc.), sulfonyloxy group (e.g., methanesulfonyloxy group, trifluoromethanesulfonyloxy group, benzenesulfonyloxy group, p-toluenesulfonyloxy group, etc.), and the like can be mentioned.
In consideration of the crystallinity of the furanose type 2-deoxy-L-ribose compound represented by formula (8), R8 and R9 are preferably p-toluoyl groups, and X1 is preferably a halogen atom, and more preferably a chlorine atom.
Protection of the 3-position and the 5-position hydroxyl groups of compound (4), and conversion of !OR7 to a leaving group can be performed according to any synthetic method of sugar, which is conventionally known to hose of ordinary skill in the art (see, e.g., Nucleosides & Nucleotides, vol. 18 (11 & 12), pp. 2357-2365 (1999)).
For example, a preferable embodiment wherein R8 and R9 are p-toluoyl groups and X1 is a chlorine atom, can be performed according to a method described in Nucleosides & Nucleotides, vol. 18 (11 & 12), pp. 2357-2365(1999).
In another embodiment, the present invention provides methods for preparing L-nucleic acid derivatives and 2′-deoxy-L-nucleosides by converting the 2-deoxy-L-ribose or derivative thereof produced by the present method to such a L-nucleic acid derivative and 2′-deoxy-L-nucleoside. The 2-deoxy-L-ribose or derivative thereof produced by the present method may be converted to such a L-nucleic acid derivative and 2′-deoxy-L-nucleoside by the methods described in, e.g., WO 01/34618 and WO 02/44194, which are incorporated herein in their entireties.
Other features of the invention will become apparent in the course of the following descriptions of exemplary embodiments which are given for illustration of the invention and are not intended to be limiting thereof.
Under an argon atmosphere, to a solution (10.8 ml, 0.5M) of (1,3-dioxolan-2-ylmethyl)-magnesium bromide in tetrahydroftiran was added tetrahydrofuran (5 ml), and after stirring, the mixture was cooled to !78° C. Thereto was slowly added a solution of 2,3-O-isopropylidene-L-glyceraldehyde (0.50 g, 3.84 mmol) in tetrahydrofuran (5 ml), and the mixture was stirred for about 2 hours. Thereafter, the temperature was allowed to return to room temperature and the mixture was stirred for 15 hours. After confirmation of complete disappearance of 2,3-O-isopropylidene-L-glyceraldehyde, which is the starting material, by thin layer chromatography (TLC) (hexane:ethyl acetate=1:1), an aqueous ammonium chloride solution was added, and the mixture was stirred. The reaction mixture was filtered to remove the salt and extracted with diethyl ether. The organic layer was washed with aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=2:1) to give 2-deoxy-4,5-O-isopropylidene-L-ribose ethylene acetal as a colorless transparent liquid (0.59 g, yield 70.8%, the 3-position R form (deoxyribose): the 3-position S form (deoxyxylose)=4.2:1).
1H-NMR(CDCl3, 400 MHz) δ 1.36(s, 3H), 1.42(s, 3H), 1.77-1.84(m, 1H), 2.04-2.09(m, 1H), 3.84-4.08(m, 8H), 5.08(t, 1H, J=4.6 Hz)
To a solution of 2-deoxy-4,5-O-isopropylidene-L-ribose ethylene acetal (70 mg, 0.32 mmol) in methanol (5 ml) was added 10%-hydrogen chloride-methanol solution (0.1 ml). After dissolution, the mixture was stirred at room temperature for about 4 hours. After confirmation of completion of the reaction by TLC (dichloromethane:methanol=95:5), the mixture was cooled to 0° C. and pyridine was added for neutralization (pH 5 to 6). Thereafter, silica gel was added, and the mixture was concentrated under reduced pressure to remove methanol, whereby the resulting product was adsorbed to silica gel. Thereafter, the product adsorbed to silica gel was purified by silica gel column chromatography (dichloromethane:methanol=98:2) to give methyl 2-deoxy-L-riboside (furanose type:pyranose type=1:4) (41 mg, yield 86.5%).
1H-NMR(CDCl3, 400 MHz) δ 1.89(dd, 2H, J=2.7 Hz, J=4.2 Hz), 2.04(d, 1H, J=7.3 Hz), 2.21(d, 1H, J=6.0 Hz), 3.35(s, 3H), 3.73-3.75(m, 3H), 4.02-4.05(m, 1H), 4.78(dd, 1H, J=2.7 Hz, J=3.0 Hz), furanose 1-position H(5.12): pyranose 1-position H(4.78)=1:4
80% Acetic acid (2.5 ml)was added to 2-deoxy-4,5-O-isopropylidene-L-ribose ethylene acetal (50 mg, 0.23 mmol), and the mixture was stirred at room temperature for about 4 hours. After confirmation of completion of the reaction by TLC (hexane:ethyl acetate=1:2), the mixture was concentrated under reduced pressure to remove water. Toluene was added thereto, and the mixture was concentrated under reduced pressure again to remove acetic acid by azeotrope. This step was repeated three times to completely remove acetic acid and water. Vacuum drying gave 2-deoxy-L-ribose (30 mg, yield 92.3%).
1H-NMR(D2O, 400 MHz) δ 1.70-2.40(m, 2H), 3.56-4.25(m, 4H), 5.30(dd, 1H, J=3.3 Hz, J=3.0 Hz)
To a solution of 2-deoxy-L-ribose (20 mg, 0.14 mmol) obtained in Example 3 in methanol (5 ml) was added 10%-hydrogen chloride-methanol solution (0.05 ml). After dissolution, the mixture was stirred at room temperature for about 2 hours. After confirmation of completion of the reaction by TLC (dichloromethane:methanol=95:5), the mixture was cooled to 0° C. and pyridine was added for neutralization (pH 5 to 6). Thereafter, silica gel was added, methanol was removed by concentration under reduced pressure, and the resulting product was adsorbed to silica gel. Thereafter, the product adsorbed to silica gel was purified by silica gel column chromatography (dichloromethane:methanol=98:2) to give methyl 2-deoxy-L-riboside(furanose type:pyranose type=1:2) (18.0 mg, yield 86.9%).
1H-NMR(CDCl3, 400 MHz) δ 1.89(dd, 2H, J=2.7 Hz, J=4.2 Hz), 2.04(d, 1H, J=7.3 Hz), 2.21(d, 1H, J=6.0 Hz), 3.35(s, 3H), 3.73-3.75(m, 3H), 4.02-4.05(m, 1H), 4.78(dd, 1H, J=2.7 Hz, J=3.0 Hz)
Under an argon atmosphere, hexane (39 ml, 0.88M) was added to methyl 2,3-O-isopropylidene-L-glycerate (5 ml, 34.5 mmol), and the mixture was cooled to !78° C. After cooling, diisobutyl aluminum hydride (0.95M hexane solution) (40 ml, 38.0 mmol) was added, and the mixture was stirred at !78° C. for 5 hours. After confirmation of completion of the reaction by TLC (hexane:ethyl acetate=2:1), aqueous ammonium chloride solution was added, and the temperature was allowed to return to room temperature. The reaction mixture was filtered and extracted with diethyl ether. The diethyl ether layer was dried over magnesium sulfate, and after filtration, concentrated under reduced pressure. Thereafter, the residue was purified by silica gel column chromatography (hexane:ethyl acetate=3:1) to give 2,3-O-isopropylidene-L-glyceraldehyde as a colorless transparent liquid (3.3 g, yield 89.9%).
1H-NMR(CDCl3, 400 MHz)δ1.42(s, 3H), 1.49(s, 3H), 4.07-4.20(m, 2H), 4.40(dt, 1H, J=1.8 Hz, J=7.0 Hz), 9.72(d, 1H, J=1.8 Hz)
Under an argon atmosphere, to a solution (37 ml, 0.5M) of (1,3-dioxolan-2-ylmethyl)magnesium bromide in tetrahydrofuran was added lithium bromide (3.2 g, 36.9 mmol), and the mixture was stirred at room temperature stirred for 30 minutes. After stirring, the mixture was cooled to 0° C., and a solution of 2,3-O-isopropylidene-L-glyceraldehyde (2.0 g, 15.4 mmol) in tetrahydrofuran (20 ml) was slowly added thereto. Thereafter, the temperature was raised to 10° C. and the mixture was stirred for about 15 hours. After confirmation of complete disappearance of 2,3-O-isopropylidene-L-glyceraldehyde, which was a starting material, by monitoring with thin layer chromatography (TLC) (hexane:AcOEt=1:1), aqueous ammonium chloride solution was added and the mixture was stirred. The reaction mixture was filtered to remove the salt, and the mixture was extracted with diethyl ether. The organic layer was washed with aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure to give 1-(2,2-dimethyl[1,3]dioxolan-4-yl)-2-[1,3]dioxolan-2-ylethanol as an orange viscous liquid (diastereoselectivity; 3R form:3S form=4.5:1), which was used in the next step without purification on the presumption that the yield was 100%.
1H-NMR(CDCl3, 400 MHz) δ 1.36(s, 3H), 1.42(s, 3H), 1.77-1.84(m, 1H), 2.04-2.09(m, 1H), 3.84-4.08(m, 8H), 5.08 (t, 1H, J=4.6 Hz)
To a solution of 1-(2,2-dimethyl[1,3]dioxolan-4-yl)-2-[1,3]dioxolan-2-ylethanol (15.4 mmol), which was an unpurified orange viscous liquid, in methanol (45 ml) was added 10% hydrogen chloride-methanol (0.46 ml). After dissolution, the mixture was stirred at room temperature for about 3 hours. After confirmation of completion of the reaction by monitoring with TLC (CH2Cl2:MeOH=90:10), the mixture was cooled to 0° C., and sodium hydrogen carbonate powder was added for neutralization (pH 6 to 7). Thereafter, methanol was removed by concentration under reduced pressure to give methyl 2-deoxy-L-riboside (furanose:pyranose=10:1) and methyl 2-deoxy-L-xyloside as an oil (crude, 2.43 g), which was used in the next step without purification on the presumption that the yield was 100%.
1H-NMR(CDCl3, 400 MHz) δ 2.02-2.30(m, 2H), 3.38 and 3.39(2s, 3H), 3.60-3.73(m, 2H), 4.03-4.20(m, 1H), 4.50(m, 1H), furanose 1-position H(5.12):pyranose 1-position H(4.78)=10:1
To a solution of methyl 2-deoxy-L-riboside(furanose:pyranose=10:1) and methyl 2-deoxy-L-xyloside (crude, 2.43 g), which was a mixed oil, in acetone (0.5 ml) was added toluenesulfonic acid monohydrate (0.05 g), and the mixture was stirred at room temperature for about 3 hours. After confirmation of completion of the reaction by monitoring with TLC (CH2Cl2:MeOH=90:10), aqueous sodium hydrogen carbonate solution was added, and 1-O-methyl-3,5-isopropylidene-2-deoxyxylose and other impurities were removed by extraction with dichloromethane. Only the aqueous layer was dried up and the object product was extracted with methanol. Thereafter, the extract was concentrated under reduced pressure to give methyl 2-deoxy-L-riboside as a yellow oil, which was used in the next step without purification on the presumption that the yield was 100%.
1H-NMR(CDCl3, 400 MHz) δ 2.02-2.30(m, 2H), 3.38 and 3.39(2s, 3H), 3.60-3.73(m, 2H), 4.03-4.20(m, 1H), 4.50(m, 1H), 5.12(H1-α) and 5.25(H1-β)(t, 1H)
To a solution of methyl 2-deoxy-L-riboside (15.4 mmol), which was an unpurified yellow viscous liquid, in acetone (25.6 ml) was added toluoyl chloride (8.0 ml, 61.6 mmol), and triethylamine (9.4 ml, 67.8 mmol) was slowly added dropwise. The mixture was stirred at room temperature for about 20 hours. After confirmation of completion of the reaction by monitoring with TLC (Hexane:AcOEt=4:1), the precipitate was removed by filtration, and the organic layer was washed with 1N hydrochloric acid, and then with aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The filtration and concentration were repeated until the precipitate was not seen, whereby 1-O-methyl-3,5-ditoluoyl-2-deoxy-L-ribose was obtained as a yellow viscous liquid, which was used in the next step without purification on the presumption that the yield was 100%.
1H-NMR(CDCl3, 400 MHz) δ 2.41(s, 6H), 3.36(s, 3H), 3.42(s, 3H), 4.46-4.65(m, 3H), 5.19(dd, 1H, H1-α, J=0.95, 5.3 Hz), 5.23(dd, 1H, H1-β, J=2.1, 5.4 Hz), 5.41(m, 1H, H3-α), 5.59(m, 1H, H3-β), 7.20-8.05(m, 8H)
To a solution of 1-O-methyl-3,5-ditoluoyl-2-deoxy-L-riboside (15.4 mmol), which was an unpurified yellow viscous liquid, in hexane (30.0 ml) was added 4N hydrogen chloride-ethyl acetate (20 ml), and the mixture was stirred at room temperature for about 3.5 hours. After confirmation of completion of the reaction by monitoring with TLC (Hexane:AcOEt=4:1), the mixture was cooled to !5° C. and stirred. After a while, crystals were precipitated. The mixture was stirred as it was for about 2 hours to allow sufficient precipitation, and the crystals were then collected by filtration. During collection, the crystals were washed with cold diethyl ether to give 1-chloro-3,5-ditoluoyl-2-deoxy-α-L-ribose as white crystals (0.70 g, yield 11.7% (total yield from 2,3-O-isopropylidene-L-glyceraldehyde)).
1H-NMR(CDCl3, 400 MHz) δ 2.41(s, 6H), 2.80(m, 2H), 4.64(m, 2H), 4.86(q, 1H), 5.55(m, 1H), 6.47(d, 1H, J=5.1 Hz), 7.24(2d, 4H, J=8.6 Hz), 7.94(2d, 4H, J=8.3 Hz)
Obviously, numerous modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein.
All patents, patent publications and other publications identified or referenced herein are incorporated in full herein by this reference in their entireties.
Although only some exemplary embodiments of this invention have been described in detail above, those skilled in the art will readily appreciated that many modifications are possible in the exemplary embodiments without materially departing from the novel teachings and advantages of this invention. Accordingly, all such modifications are intended to be included within the scope of this invention.
| Number | Date | Country | Kind |
|---|---|---|---|
| 071101/2004 | Mar 2004 | JP | national |
| 272619/2004 | Sep 2004 | JP | national |
This application claims priority to U.S. Provisional Patent Application No. 60/574,216, filed on May 26, 2004; Japanese Patent Application No. 071101/2004, filed on Mar. 12, 2004; and Japanese Patent Application No. 272619/2004, filed on Sep. 17, 2004, all of which are incorporated herein by reference in their entireties.
| Number | Date | Country | |
|---|---|---|---|
| 60574216 | May 2004 | US |
